Work

100.36 Ischemic Versus Bleeding Risk Consideration for the Duration of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions

Year: 2019

Type: article

Source: JACC: Cardiovascular Interventions

DOI: 10.1016/j.jcin.2019.01.040

Authors: Deepakraj Gajanana, Toby Rogers, Micaela Iantorno, William Weintraub, Evan Shlofmitz, Nauman Khalid, Yuefeng Chen, Rebecca Torguson, Jaffar Khan, Anees Musallam, Itsik Ben-Dor, Lowell Satler, Ron Waksman

Institution: MedStar Washington Hospital Center

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2916792447

FWCI:

Cites:

Cited by:

Related to: 10